MassMutual Private Wealth & Trust FSB lifted its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 142.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 112,808 shares of the conglomerate's stock after acquiring an additional 66,309 shares during the period. MassMutual Private Wealth & Trust FSB's holdings in Danaher were worth $24,993,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the company. First Command Advisory Services Inc. raised its position in Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate's stock valued at $253,000 after purchasing an additional 47 shares in the last quarter. Studio Investment Management LLC boosted its holdings in shares of Danaher by 3.3% in the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate's stock worth $302,000 after purchasing an additional 51 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 53 shares during the last quarter. JDH Wealth Management LLC raised its holdings in shares of Danaher by 4.5% during the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate's stock valued at $240,000 after buying an additional 55 shares in the last quarter. Finally, OneAscent Financial Services LLC raised its holdings in shares of Danaher by 5.5% during the 4th quarter. OneAscent Financial Services LLC now owns 1,069 shares of the conglomerate's stock valued at $245,000 after buying an additional 56 shares in the last quarter. Institutional investors own 79.05% of the company's stock.
Danaher Stock Down 0.0%
Shares of Danaher stock opened at $214.03 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock has a market capitalization of $150.46 billion, a price-to-earnings ratio of 38.02, a P/E/G ratio of 2.67 and a beta of 0.76. The company's 50 day moving average price is $209.20 and its 200-day moving average price is $193.70.
Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm's revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.77 EPS. Equities research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher's dividend payout ratio is 28.42%.
Analysts Set New Price Targets
Several analysts have issued reports on DHR shares. Stifel Nicolaus cut their target price on Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Guggenheim upped their price objective on shares of Danaher from $200.00 to $250.00 and gave the company a "buy" rating in a research note on Thursday. Evercore reaffirmed an "outperform" rating and set a $230.00 target price on shares of Danaher in a report on Monday, July 6th. Finally, Weiss Ratings upgraded shares of Danaher from a "hold (c-)" rating to a "hold (c)" rating in a research report on Wednesday, September 16th. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, Danaher has a consensus rating of "Moderate Buy" and an average price target of $232.50.
Get Our Latest Report on DHR
Danaher Company Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
Read More
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.